orlistat vs semaglutide New GLP pill, orforglipron, versus established GLP pill, in those with obesity & type 2 diabetes. 1️⃣Average blood sugar improved slightly more with orforglipron (reduced HbA1c by 2.2% from baseline 8.3%) 🌎Current FDA approved drugs for

Inconsistent dosing creates inconsistent side effects, which disrupts training schedules in ways that are difficult to plan around

Constipation develops because tirzepatide slows gastric motility throughout the entire digestive tract, not just the stomach

Separately, observational studies have reported rare cases of non-arteritic anterior ischaemic optic neuropathy (NAION) in patients using semaglutide

Therefore, precise elucidation of the pathogenic mutations in the NCPs will help the development of targeted therapeutic and preventive tools

At the end of week 16, the use of semaglutide was discontinued and the participants underwent regular follow-up outpatient controls to monitor their anthropometric, biochemical and hormonal parameters

This gap, this unexplained remainder, is the fertile ground from which the GLP-3 hypothesis grew